Hematopathology Flashcards

1
Q

RBC Life Cycle/ Structure

A
  • EPO → normoblasts → loss of nucleus → reticulocytes → mature RBC
  • Reticulocyte stage: 5-7 days
  • RBC life span: 120 days
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

RBC Parameters (4)

A

• Mean Cell Volume (MCV): average volume of an RBC • Mean Cell Hemoglobin (MCH): average content of Hb per RBC • Mean Cell Hemoglobin Concentration (MCHC): average concentration of Hb in a given volume of RBC’s • Red Cell Distribution Width (RDW): coefficient of variation of RBC volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hemolytic Anemias

A

ETIOLOGY:

  • Intravascular Hemolysis: mechanical injury to RBC
  • Defective cardiac valves
  • Microvascular thrombi
  • Complement Fixation
  • Infections (malaria, clostridia toxin)
  • Extravascular Hemolysis: RBC rendered deformed or foreign
  • Spherocytosis
  • Sickle Cell anemia
  • Immune antibody coating

PATHOGENESIS: shortened RBC life span - increased erythropoietin and erythropoiesis

  • Intrinsic RBC Defect: membrane defect (spherocytosis), enzyme defect (G6PD), hemoglobin defect( Sickle cell and Thalassemias)
  • Extrinsic RBC Defect: Immune mediated damage, trauma, infections Acute Hemorrhage - hypovolemia chronic Hemorrhage - iron stored becomes depleted

MORPHOLOGY:

  • normochromic, normocytic anemia
  • Polychromasia
  • Erythroid hyperplasia
  • Increased bilirubin, hemoglobin, and LDH
  • Decreased Haptoglobin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hereditary Spherocytosis

A

ETIOLOGY: mutated proteins in the RBC membrane skeleton

  • Northern Europeans
  • Autosomal dominant

MORPHOLOGY: RBCs become spheroid and rigid

• With splenectomy → Howell-Jolly Bodies (DNA remains left due to splenectomies)

PATHOGENESIS: reduced RBC membrane stability → 10-20 day life span

  • Ankyrin
  • Band 3
  • Spectrin
  • Band 4.2
  • Reduced RBC membrane stability → loss of small fragments during normal shearing stresses in the blood circulation → RBCs become increasingly more spherical → unable to traverse the splenic sinusoids → phagocytosis and destruction by splenic macrophages (spleen usually enlarged)

SYMPTOMS: chronic hemolytic anemia, gall stones (increased bilirubin)

  • TREATMENT: splenectomy → anemia corrects, spherocytosis persists
  • DIAGNOSIS:
  • Osmotic Fragility Test: when exposed to hypotonic salt solutions → RBCs lyse prematurely
  • Increased MCHC (only one)
  • Increased LDH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

G6PD Deficiency

A
  • ETIOLOGY: abnormality in the Hexose Monophosphate Shunt due to impaired enzyme function - leaves RBC’s prone to oxidative injury
  • X-linked recessive
  • G6PD Type B = most common
  • African Americans (Type A)
  • Mediterranean/Middle Eastern (Type B)
  • PATHOGENESIS: exposure to oxidants (abnormal protein folding and increased proteolytic degradation) → oxidation of SH groups on globin chains → precipitation of denatured globins = Heinz bodies
  • severe damage → RBC to spleen → macrophage bite out inclusions → bite cells → extravascular hemolysis
  • Presentation follows infection, Sulfa drugs, fava beans
  • SYMPTOMS:
  • Acute hemolysis
  • Neonatal jaundice (uncommon)
  • Heterozygote advantage against P. falciparum malaria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sickle Cell Disease (HbS)

A
  • ETIOLOGY: point mutation at position 6 in B-globin chain (glutamic acid → valine)
  • 10% of African Americans are HbAS (heterozygotes)

PATHOGENESIS: HbS aggregate during crises (sticky) - formation of long-needle like structures

SICKLING FACTORS:

  • Amount of HbS & its interaction with other Hb chains in the red cell:
  • HbA & HbF decrease sickling; HbC sickling increased. - Hb concentration per red cell: Dehydration increased sickling Coexisting α-thalassemia decreases sickling (less globin, therefore less hemoglobin). - Acidity: lower pH increases sickling. -Length of exposure to low O2 tension.

CRISIS

  • Vaso-occlusive/ painful crises: ischemic events due to microvascular occlusions
  • Sequestration crises: rapid pooling of blood in the spleen.
  • Aplastic crises: acute viral infection, due to parvovirus B19 (infects red cell precursors).
  • Hemolytic crises.

MORPHOLOGY: target cells

SYMPTOMS:

  • Chronic hemolysis (intravascular & extravascular)
  • Hyperplastic bone marrow → skull bone changes in kids
  • Repeated infarction and fibrosis → Autosplenectomy in children → susceptible to H. influenzae and Pneumococcus
  • Jaundice
  • Microvascular occlusions
  • Osteomyelitis with Salmonella infections
  • Aplastic crises: acute viral infection (Parvo B19)

DIAGNOSIS: mixing blood with O2 consuming agent induces sickling

• Hemoglobin electrophoresis

TREATMENT: analgesics, B9, Hydroxyurea (increases HbF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

B-Thalassemias

A
  • ETIOLOGY: diminished synthesis of structurally normal B-globin chains (chromosome 11), with unimpaired alpha-chain production
  • B+ Thalassemia: reduced B chains produced (mutation in promoter)
  • B(o) Thalassemia: no B chains (mutation in splicing or chain termination) •

PATHOGENESIS: reduced survival of RBCs due to cell membrane damage by precipitated alpha-chains → ineffective erythropoiesis

  • 75% of RBC precursors die in bone marrow
  • Excessive iron absorption
  • MORPHOLOGY: hypochromic, microcytic anemia
  • Target cells
  • TREATMENT: bone marrow transplants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

B-Thalassemia Major Syndrome

A
  • ETIOLOGY: presents 6-9 months after birth when HbF levels naturally fall
  • Mediterranean, Africa, SE Asia
  • PATHOGENESIS: B+/B+, B+/B(o), B(o)/B(o) = severe transfusion-dependent anemia

SYMPTOMS: • Expansion of hematopoietic marrow → prominent facial bones, erosion of bony cortex, new bone formation

  • Hepatosplenomegaly → due to extravascular hemolysis
  • Hemosiderosis
  • Secondary hemochromatosis due to iron overload → cardiac failure, liver failure, pancreatic damage - growth retardation + death → unless given blood transfusion

DIAGNOSIS: • Hb levels = 3-6 g/dL

• HbF remains elevated

TREATMENT: iron chelator to prevent iron overload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

B-Thalassemia Minor

A

• PATHOGENESIS: B+/B or B(o)/B = mild hypochromic, microcytic anemia

SYMPTOMS: usually asymptomatic

• DIAGNOSIS: hemoglobin electrophoresis: increased HbA2 with normal or elevated HbF

TREATMENT: avoid treating as iron-deficiency anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A-Thalassemia

A
  • Silent Carrier: one alpha-gene deleted
  • A-Thalassemia Trait: 2 genes deleted
  • a/a, -/- (SE Asian)
  • a/-, a/- (African)
  • Hemoglobin H Disease: 3 genes deleted
  • HbH is formed from tetramers of excess B-chains → high affinity for O2 → hypoxia
  • HbH oxidation →precipitated inclusions in RBCs → spleen → extravascular hemolysis
  • Hydrops Fetalis: all 4 genes deleted (incompatible with life)
  • Hb Barts formed from tetramers of excess gamma-chains → high affinity for O2 → no O2 reaches the tissues → death unless given intrauterine transfusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Paroxysmal Nocturnal Hemoglobinuria (PNH)

A
  • ETIOLOGY: rare acquired clonal stem cell disorder associated with periodic hemolysis
  • X-linked
  • Phosphatidylinositol glycan class A (PIGA)

PATHOGENESIS: PIGA gene synthesizesglycosylphosphatidyl inositol (GPI)

  • GPI (anchors CD55/CD59) inhibits complement activation on blood cells
  • At night → hypoventilation → decreased pH → complement activated
  • PNH is rare → PIGA clones gain selective advantage to produce disease

SYMPTOMS: intravascular hemolysis, pro-thrombotic state (40% develop venous thrombosis)

  • Hemoglobinuria, hemosiderinuria
  • Iron deficiency
  • Aplastic anemia
  • 5-10% develop AML or Myelodysplastic Syndrome

DIAGNOSIS:

  • Sucrose hemolysis test (screening)
  • Ham’s Acid hemolysis test
  • Flow Cytometry: absence of CD55 and CD59 on WBC’s
  • Flaer Test

TREATMENT: Immunosuppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Warm Antibody Immunohemolytic Anemia

A
  • ETIOLOGY: most common form of IHA
  • 50% are idiopathic
  • 50% have predisposing autoimmune disease, lymphoma or drug reactions • Most antibodies are IgG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cold Antibody Immunohemolytic Anemia

A
  • ETIOLOGY: IgM antibodies bind and agglutinate RBCs at <4C SYMPTOMS: • Acute Self-limiting Hemolysis: seen in infectious diseases (CMV, HIV, Influenza, Mycoplasma pneumonia)
  • Chronic Hemolysis: idiopathic or associated with lymphoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Direct Antiglobulin Test (DAT):

A

Detection of antibodies ± complement on patient RBCs. Patient RBCs are incubated with antibodies to these elements → RBC agglutination - anti- antibodies → bind to patient RBC’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Indirect Antiglobulin Test (IDAT):

A
  • Patient serum is tested for its ability to agglutinate test RBCs that have known antibodies bound onto them. -Temperature dependence defines “warm” or “cold”.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Megaloblastic Anemias

A
  • ETIOLOGY: deficiency of Vitamin B12 (cobalamine) or B9 (folate)
  • Poor people, pregnant women, alcoholics, overcooked food, impaired absorption

PATHOGENESIS: both vitamins are coenzymes required for synthesis of thymidine (methionine synthase, thymidylate synthase)

  • B9 → Impaired DNA synthesis → ineffective erythropoiesis → destruction of macrocytes
  • B12 → Autoantibodies → Blocked IF (parietal cells) → B12 def. → Megaloblastic anemia
  • MMA requires cobalamin. B12 deficiency increases urine methyl malonic acid -Neurological deficits → dorsal and lateral tracts affected: sensory and functional functions affected
  • MORPHOLOGY: pancytopenia with macrocytic anemia
  • (MCV>100)
  • Decreased reticulocyte count
  • Enlarged hyper-segmented neutrophils (5+ lobes)
  • Hypercellular bone marrow
  • Increased homocysteine

SYMPTOMS: Fatigue, atrophic glossitis, cheoilsosis

• Neurological symptoms → B12 ONLY → Decreased vibration/proprioception, degeneration of dorsal/lateral tracts of CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pernicious Anemia

A

• Type II Hypersensitivity

ETIOLOGY:

  • Decreased intake (diet deficient → strict vegetarian)
  • Impaired GI absorption → pernicious anemia, malabsorption (IF defect)
  • Common in N. Europeans, ages 40-80

PATHOGENESIS: autoimmune atrophic gastritis → failure of IF production → B12 not absorbed → B12 deficiency → Megaloblastic anemia

  • SYMPTOMS: CNS deficits → sensory ataxia, lower limb parasthesia
  • Atrophic gastritis
  • DIAGNOSIS:
  • Increased plasma and urine methyl-malonic acid
  • Increased serum homocysteine
  • Increased MCV
  • Decreased reticulocytes
  • Schilling Test: inability to absorb oral B12
  • Reticulocyte Response: improvement of anemia 5 days after paraenteral B12 injections
  • serum antibodies to intrinsic factor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Folate Deficiency

A
  • ETIOLOGY:
  • Decreased intake: inadequate intake of green vegetables (alcoholics)
  • Impaired GI absorption
  • Increased requirements (pregnancy, infancy, cancer therapy)

SYMPTOMS: no CNS symptoms DIAGNOSIS:

  • Increased homocysteine
  • Decreased serum folate (differentiation b/w B12 deficiency)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Iron Deficiency Anemia

A

• Microcytic hypochromic anemia

ETIOLOGY: most common cause of anemia worldwide

  • Dietary deficiency
  • Impaired absorption ( normally absorbed in the duodenum)
  • Increased requirements: growing infants, premenopausal female, pregnancy
  • Chronic blood loss (most commonly due to chronic GI blood loss)

DIAGNOSIS:

  • CBC: decreased Hb, decreased MCV, increased RDW
  • Blood Smear: hypochromic microcytic anemia, sometimes poikilocytosis (pencil cells)
  • Biochemical: decreased transferrin saturation, increased TIBC, decreased ferritin
  • Depletion of BM iron stores: Prussian Blue stain of bone marrow is negative

NORMAL METABOLISM: mostly absorbed in the duodenum

  • Hepcidin: inhibits ion uptake from duodenal mucosal cells in response to high levels of iron stores
  • Free iron is toxic → Fe is bound as ferritin
  • Storage: ferritin (in liver, spleen, BM, muscle) + hemosiderin
  • Transport: transferrin
  • Functional iron → 80% is bound to hemoglobin

SYMPTOMS: Koilonychia, decreased reticulocytes, MCV, MCHC

  • Plummer Vinson Syndrome = Iron deficiency anemia, proximal esophageal webs, atrophic glossitis
  • Pica Syndrome = Eat dirt, ice (psychiatric problems)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Anemia of Chronic Disease

A
  • ETIOLOGY:
  • Chronic bacterial infections: lung abscesses, endocarditis, tuberculosis
  • Chronic immune disorders: rheumatoid arthritis
  • Malignant tumors: lung, breast, lymphoma

PATHOGENESIS: impaired iron utilization and decreased RBC production

  • Increased Hepcidin → decreased transfer of iron from bone marrow pool to RBC precursors due to inflammatory mediators
  • Decreased erythropoiesis with low EPO
  • MORPHOLOGY: hypochromic, microcytic anemia

DIAGNOSIS: decreased serum Fe, decreased TIBC (transferritin) , increased ferritin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Aplastic Anemia

A
  • ETIOLOGY: pancytopenia → bone marrow failure due to defect in multi-potent hematopoietic stem cell
  • Congenital/Hereditary (Fanconi anemia)
  • Myelophthisic Anemia: bone marrow replaced by abnormal infiltrates (granulomas)
  • Chronic Renal Disease: decreased EPO
  • Acquired:
  • Idiopathic (65%) - immune mediated destruction of altered stem cells -primary intrinsic stem cell defect
  • Chemical Agents (35%) → chemotherapy, chloraphenicol, chloropromazine, phenytoin
  • Viral: CMV, EBV, VZV
  • PATHOGENESIS: bone marrow failure due to auto-reactive T cell defect in a multipotent hematopoietic stem cell

COMPLICATIONS: recurrent infections

DIAGNOSIS: low reticulocyte count

• BM Biopsy: hypocellular, often only fat cells, stroma and scattered lymphocytes

22
Q

Infectious Mononucleosis

A
  • ETIOLOGY: Patients with EBV “kissing disease”
  • PATHOGENESIS: Infects B cells in the oropharyngeal epithelium → B cells spread infection → T lymphocyte response is essential to control, but is ineffective

MORPHOLOGY: Atypical lymphocytes: Downey cells

• RBC’s pushing into the cytoplasm (ballerina skirt appearance)

SYMPTOMS: Fatigue, sore throat, fever, lymphadenopathy

• Atypical: Hepatitis, febrile rash, hepatosplenomegaly

COMPLICATIONS: Splenic rupture → hypovolemic shock

• Non-Hodgkin B cell lymphoma

23
Q

Polycythemia

A

• ETIOLOGY: abnormally elevated RBC concentration and Hb levels

PATHOGENESIS:

  • Relative Polycythemia: due to reduced plasma volume (secondary to dehydration)
  • Absolute Polycythemia:
  • Primary: JAK2 mutation → Polycythemia Vera (PRV) → chronic myeloproliferative neoplasm (low EPO)
  • Secondary: appropriately high EPO levels (lung disease, cyanotic heart disease, living at high altitude) or inappropriately high EPO levels (EPO secreting tumors of kidney)
24
Q

Thrombocytopenia

A
  • Decreased production
  • Generalized bone marrow disease
  • Aplastic anemia
  • Marrow infiltration (leukemias, metastasis, granulomas)
  • Drug-induced (ethanol)
  • HIV
  • Megaloblastic anemia
  • Myelodysplastic syndromes
  • Decreased survival
  • Immune Destruction: antiplatelet antibodies or immune complexes (ITP, SLE)
  • Drug associated: heparin, septrin, quinidine
  • Non-immune: DIC, TTP/HUS, mechanical destruction, Giant hemongiomas, Microangiopathic hemolytic anemias

CAUSES - decreased platelet production - decreased platelet survival sequestration ( splenic) -dilutional

  • INVESTIGATIONS: ↓Platelet count, ↑BT, Normal PT, PTT
  • SYMPTOMS: Excessive bleeding, petechiae, ecchymosis, epistaxis, mucosal bleeding, CNS
25
Q

Primary Immune Thrombocytopenia (ITP)

A
  • Acute: children, post-viral with abrupt on set and spontaneous resolution
  • Chronic: more common, women 20-40 with mucosal bleeding
  • DIAGNOSIS: decreased, but large platelets
  • Increased bleeding time
  • Autoantibodies against platelet membrane glycoproteins
  • Increased megakaryocytes in BM biopsy
  • TREATMENT: splenectomy
26
Q

Non-Immune Thrombocytopenias (TTP/HUS)

A
  • Thrombotic Thrombocytopenic Purpura: clinical syndrome of fever, thrombocytopenia, micro-angiopathic hemolytic anemia neurological defects (ADULTS) + Renal Failure
  • Hemolytic Uremic Syndrome: clinically like TTP but no neurological deficits but prominent renal failure (CHILDREN)
  • In common:
  • Platelet thrombi → small vessels occlusion + mechanical microangiopathic hemolytic anemia
  • Platelet consumption → thrombocytopenia
27
Q

Von Willebrand Disease

A
  • ETIOLOGY: commonest inherited disorder of bleeding. Defect in platelet-to-collagen adhesion
  • Type 1 (70%): reduced quantity of VWF → mostly mucosal bleeding
  • Type 2 (25%): qualitative (functional) defect in VWF - mild to moderate bleeding
  • Type 3 (5%): severe deficiency of VWF → patient may present like Hemophilia A
  • Increased BT, PTT, normal platelet count
28
Q

Hemophilia A

A

• ETIOLOGY: X-linked recessive, but 30% from new mutations

PATHOGENESIS: Factor VIII deficiency

SYMPTOMS: massive bleeds after trauma or surgery

• Spontaneous hemorrhages following minimal trauma to joints or muscles

DIAGNOSIS: prolonged PTT

• Normal platelets, BT, PT

TREAMTMENT: recombinant Factor VIII infusions → risk of transmission of viral disease

29
Q

Lymphopenia

A
  • ETIOLOGY: too few white blood cells
  • Advanced HIV
  • DiGeorge’s Syndrome
  • Drug-Induced: chemotherapy, steroid therapy
  • Autoimmune disease
  • Acute viral infections
30
Q

Neutropenia

A
  • PATHOGENESIS:
  • Reduced production (bone marrow issue):
  • Suppression of myeloid stem cells (aplastic anemia)
  • Suppression of myeloid precursors (drug-induced)
  • Megaloblastic anemias, myelodysplastic syndromes
  • Marrow infiltration (granulomas, tumors, inflammation)
  • Kostmann Syndrome (acquired neutropenia)
  • Accelerated consumption (peripheral issue):
  • Splenic sequestration (splenomegaly)
  • Overwhelming infection. (increased consumption)
  • TREATMENT: G-CSF, broad-spectrum antibiotics (for infections)
  • SYMPTOMS:
  • Agranulocytosis: severe neutropenia, prone to life-threatening infection
  • Usually drug-induced (chemotherapy)
31
Q

Neutrophilic Leukocytosis

A

(too many cells)

  • Infections: pyogenic bacteria
  • Inflammation: MI, burns, trauma, surgery, gout, RA
  • Acute hemorrhage
  • Malignancy
32
Q

Eosinophilic Leukocytosis

A
  • Allergic disorders (asthma, hay fever)
  • Skin diseases (bullous pemphigus, dermatitis herpetiformis)
  • Parasitic infestations
  • Drug reactions
33
Q

Basophilic Leukocytosis

A

• Almost always indicates chronic myeloid leukemia

34
Q

Monocyte Leukocytosis

A
  • Chronic infections (TB, Rickettsiosis, Endocarditis, Malaria, SLE)
  • Inflammatory Bowel Disease
35
Q

Lymphadenopathy

A
  • CHILDREN: reactive lymphadenopathy is common → nodes are tender with history of infection or rash ( NO biopsy)
  • IN ADULTS: reactive adenopathy is less likely; there is increased concern for malignancy
  • Fine needle aspiration or tissue biopsy
36
Q

Leukemia:

A

neoplasia involves predominantly bone marrow

37
Q

Lymphoma:

A

neoplasia forms discrete tissue masses (lymph nodes or extranodal)

38
Q

Lymphoid Neoplasms

A
  • LYMPHOMAS:
  • 60% of NHL and all HL → non-tender lymph node enlargement
  • 40% of NHL → extranodal (site-related symptom)
  • B-cell neoplasms show light chain restriction, detectable by flow cytometry or immunohistochemical stains ( expressing either Kappa or Lambda chains)
  • Non-Hodgkin’s Lymphoma (B-cell lymphomas = 90%)
  • Precursor B-Cell
  • Mature (Peripheral) B-Cell
  • Precursor T/NK Cell
  • Mature T/NK cell
  • Hodgkin’s Lymphoma
  • LEUKEMIAS: • Symptoms and signs related to bone marrow replacement → cytopenias
  • PLASMA CELL NEOPLASMS:
  • Bone destruction → bone pain due to fractures
  • blood = M components
  • Urine = Bence Jone Proteins
39
Q

Follicular Lymphoma

A
  • ETIOLOGY: middle aged 40-60 → tumor of germinal centers
  • PATHOGENESIS: t(14;18) → Bcl-2 overexpression (anti-apoptosis)
  • MORPHOLOGY: nodular vs. mixed/diffuse, small cells vs. large cells
  • Diffuse pattern + many large cells = more aggressive

SYMPTOMS: painless, generalized lymphadenopathy, obstructive jaundice due to favoritism of 2nd part of duodenum

DIAGNOSIS: CD19, CD20, CD10+

• Often Stage IV at diagnosis

OUTCOME: 40% progress to Diffuse Large B-Cell Lymphomas (DLBL)

• Not curable

40
Q

Diffuse Large B-Cell Lymphoma (DLBL)

A
  • can be primary “De Novo” or Secondary to transformation of a pervious low grade lymphoma
  • ETIOLOGY: 60 years old
  • MORPHOLOGY: diffuse, large cells. Grow in sheets w/ mixed cells

SYMPTOMS: fever, weight loss, night sweats

  • 60% present in late adulthood in lymph nodes (single mass)
  • 40% present as an extranodal mass (GI tract, skin)

DIAGNOSIS: often Stage I or II at diagnosis

OUTCOME: moderately aggressive, but potentially curable

• Chemotherapy

41
Q

Chronic Lymphocytic Leukemia (CLL) Small Lymphocytic Lymphoma (SLL)

A
  • ETIOLOGY: CLL is the most common adult leukemia (WBC>4000) (BM → blood)
  • 5% may present or progress to Small Lymphocytic Lymphoma (WBC<4000) (Only in lymph)
  • MORPHOLOGY: almost mature lymphocytes → smudge cells (fragile)
  • Bone marrow: Interstitial nodules
  • Lymph node: diffuse pattern of small round lymphocytes
  • SYMPTOMS: • Early: incidental finding of lymphocytosis
  • Later: symptoms related to cytopenias + BM replacement
  • Autoimmune hemolytic anemia / thrombocytopenia
  • Enlarged lymph nodes, hepatosplenomegaly
  • Recurrent infections
  • DIAGNOSIS: CD5, CD19, CD20, CD23, CD43+
  • OUTCOME: Cause of death: pancytopenia → recurrent infections
  • Richter’s Transformation → progression to DLBL
42
Q

Marginal Zone Lymphoma (MALToma)

A

• ETIOLOGY: lymphoma of small, mature lymphocytes

PATHOGENESIS: common site is stomach, superimposed on Helicobacter gastritis - antibiotic treatment of Helicobacter gastritis has caused regression of some earlier MZL’s

• Other sites: salivary gland or thyroid gland → secondary to autoimmune inflammation •

Graves / Hashimotos

  • Sjorgens Syndrome
  • Remain localized for long periods before spreading
  • TREATMENT: antibiotics, resection
43
Q

Burkitt Lymphoma (BL)

A
  • ETIOLOGY: aggressive B-cell neoplasm associated with EBV
  • African (endemic): 100% EBV → mainly kids / young adults
  • HIV-associated: 25% EBV
  • Sporadic: 15% EBV → mainly kids / young adults

PATHOGENESIS: c-MYC translocation to Ig heavy chain loci

  • t(8;14)- most common
  • t(2;8)
  • t(8;22)

MORPHOLOGY: Starry-sky pattern → high mitotic rate + high apoptosis = increased macrophages

SYMPTOMS: presents as extranodal mass

  • Africa (Endemic): mandible, abdominal viscera (kidneys, ovaries, adrenals)
  • Sporadic: ileocecal

DIAGNOSIS: CD10, CD19, CD20

• Monospot (+) → Test for EBV/Mono

44
Q

Hairy Cell Leukemia

A

• ETIOLOGY: rare, males > females

MORPHOLOGY: cells with round/kidney shaped nuclei and pale blue cytoplasm with thread-like extensions

  • Bone marrow: infiltration of small lymphocytes (fried-egg appearance), enmeshed in reticulin
  • Spleen: red pulp infiltration → beefy-red appearance
  • SYMPTOMS: pancytopenia and splenomegaly
  • DIAGNOSIS: CD11c, CD20, CD25, CD103+
  • Fibrosis means marrow cannot be aspirated → Dry-Tap
  • Good biopsy is important (TRAP stain positive)
45
Q

Multiple Myeloma

A
  • ETIOLOGY: 50-60 years, M > F, African American
  • Monoclonal gammopathy
  • SYMPTOMS:
  • Plasma cells secrete IL-6 → osteoclasts → bone destruction (lumbar spine > ribs > skull) → back pain
  • Bacterial infections due to neutropenia and hypogammaglobulinemia
  • Renal insufficiency due to hypercalcemia, Bence-Jones proteins, AL deposition
  • Organomegaly (spleen, liver, LN, lung)
  • Pancytopenia - due to Marrow replacement
  • MORPHOLOGY:
  • PB: RBC Rouleaux formation (stack of coins)
  • X-ray: punched out lesions in bone
  • DIAGNOSIS:
  • M-protein in serum or urine
  • Bence-Jones protein in urine
  • TREATMENT: chemotherapy (60% remission), BM transplant (if young)
46
Q

Hodgkin’s Lymphoma

A
  • ETIOLOGY:
  • Classical HL: CD15+, CD30+, CD45-
  • Nodular Sclerosis (65%)
  • Mixed Cellularity (25%)
  • Lymphocyte-predominant
  • Lymphocyte-depleted (5%)
  • Variant (L&H) HL: CD15-, CD20+, CD30-, CD45+
  • Lymphocyte predominant
  • SYMPTOMS:
  • Nodular Sclerosis: adolescents/ young adults, stage I or II at diagnosis
  • Mixed Cellularity: diffuse nodal replacement, EBV+, advanced stage at presentation
  • Lymphocyte Depleted: elderly or HIV+, EBV+, advanced stage at presentation
  • Variant HL: <35 years old, <5% transform to Non-Hodgkin’s B-cell lymphoma •

Enlargement of one or more lymph notes, pain in involved nodes after drinking alcohol, itching

  • MORPHOLOGY: Reed-Sternberg Cell = bi-nucleated (owl-eye appearance) • Nodular Sclerosis: large nodules surrounded by thick fibrous collagen bands, Lacunar RS Cells
  • Mixed Cellularity: eosinophilia (IL-5 secreted by RS cell)
  • Variant: large nodules with no collagen fibrosis, RS cells called ”popcorn cells”
  • STAGING: (1) single LN, (2) 2+ LN, (3) LN’s on both sides of diaphragm, (4) disseminated to organs
  • COMPLICATIONS: long-term survivors get secondary cancers → AML, lung cancer
47
Q

Acute Lymphoblastic Leukemia (ALL)

A
  • ETIOLOGY:
  • B-Cell types (85%) → CD10, CD19, CD20 → childhood
  • T-Cell types (15%) → CD2-8, but no CD10 → adolescent males
  • Associated with Down Syndrome - Granules + Auer Rod
  • SYMPTOMS: abrupt and severe onset
  • Bone pain
  • Generalized lymphadenopathy
  • Hepatosplenomegaly
  • Testicular enlargement (B-ALL)
  • CNS: headaches, blurred vision, vomiting (B-ALL)
  • Thymic enlargement (T-ALL)
  • PROGNOSIS:
  • Good: 2-10 years old, low WBC count, Pre B-Cell, t(12;21), hyperdiploidy
  • Poor: <2 years or teen/adult, >100,000 WBC, t(9;22), all other abnormalities
  • TREATMENT: chemotherapy, but requires prophylaxis for scrotum •

DIAGNOSIS: PAS staining, TdT+

48
Q

Acute Myeloid Leukemia (AML)

A
  • ETIOLOGY: adult, >60 years old → 20%< increase in blast cells
  • t(15;17), t(8;21) → best prognosis, t(16;16)
  • Deletion/monosomy of chromosome 5&7 → worst prognosis
  • Acute Promyelocytic (M3) → MPO, interferes with retinoic acid (RAR) receptor
  • Acute Monocytic (M5) → No MPO, infiltration of gums
  • Acute Megakaryocytic (M7) → No MPO, common in Down Syndrome
  • PATHOGENESIS: translocations disrupt transcription factors for normal differentiation
  • Chimeric genes → abnormal fusion proteins → block differentiation
  • Aberrant tyrosine kinases → increased cellular proliferation •

MORPHOLOGY: irregular WBCs, punched-out nuclei with auer rods/MPO granules

  • SYMPTOMS:
  • Anemia → fatigue
  • Neutropenia → fever, sepsis
  • Thrombocytopenia → spontaneous bleeds
  • DIC – M3 t(15;17) - bone pain + organ enlargement
  • DIAGNOSIS: circulating blast cells, WBC count elevated (blasts count as WBCs), bone marrow aspirate
  • TREATMENT: t(15;17) AML → All-trans-retinoic-acid (ATRA) → neutrophil differentiation, prevents DIC
  • Combination chemotherapy and bone marrow transplantation
  • treat with Vit A
49
Q

Myelodysplastic Syndromes (MDS)

A
  • ETIOLOGY: clonal maturation defects in stem cells → ineffective hematopoiesis → cytopenia
  • Idiopathic/Primary: >50 years old, gradual onset
  • Therapy-induced: 2-8 years old, post-chemo/radiation
  • MORPHOLOGY
  • PB: macrocytic anemia, cytopenias
  • BM: hypercellular, but disorganized, ineffective hematopoesis •

SYMPTOMS

  • Transformation to AML (10-40%)
  • Death due to cytopenias
  • DIAGNOSIS: <20% blast cells
  • Abnormal chromosome 5&7
50
Q

Chronic Myeloid Leukemia

A
  • ETIOLOGY: defect in pluripotent stem cell for myeloid and lymphoid lineages → uncontrolled proliferation with full differentiation (especially granulocytes)
  • M>F, 25-60 years old
  • PATHOGENESIS: t(9;22) translocation → Bcr-abl → aberrant TK
  • SYMPTOMS: gradual onset of tiredness, weakness, loss of weight and appetite, itching after hot showers, splenomegaly
  • Stable Phase: 3 years without treatment
  • Accelerated phase: 2-5 years → increasing blasts, fibrosis
  • Blast crisis: acute leukemia
  • DIAGNOSIS:
  • PB: left-shifted leukocytosis ( increase in neutrophils, eosinophils, and basophils)
  • BM: 100% cellular, increase granulocytic precursors ( increased megakaryocytes)
  • TREATMENT: Imatinib (Gleevec) → inhibits TK
  • Interferon-alpha → slows down disease
  • Hydroxyurea → gentle chemotherapy
  • BM transplant (effective in younger patients)
51
Q

Primary Myelofibrosis

A
  • PATHOGENESIS: JAK2 point mutations
  • Increased megakaryocytes → increased TGF-b/PDGF → BM fibrosis → pancytopenia
  • MORPHOLOGY:
  • PB: nucleated RBC precursors (tear-drop shaped)
  • BM: fibrotic, hypocellular
  • SYMPTOMS: fibrosis of bone marrow causes pancytopenia
  • Massive extramedullary hematopoiesis → hepatosplenomegaly
  • DIAGNOSIS: Dry-Tap aspiration → thus biopsy must be done
52
Q

Chronic Myeloproliferative Neoplasms

  1. Chronic Myeloid Leukemia (CML)
  2. Polycythemia Vera (PV)
  3. Essential Thrombocytosis (ET)
  4. Primary Myelofibrosis (MF)
A
  • Disorders of a pluripotent progenitor cell, capable of uncontrolled proliferation with full differentiation.
  • Tumour cells circulate &; home to 2º hematopoietic organs (spleen, liver) → organomegaly.
  • Pathogenesis - Arise from a multipotent progenitor cells, capable of uncontrolled proliferation with full differentiation. Common pathogenic feature = mutated, constitutively activated tyrosine kinases circumvent normal growth controls. Result is growth factor-independent proliferation and survival of marrow precursors.